COV — Covalon Technologies Share News
0.000.00%
Last trade - 00:00- CA$59.66m
- CA$44.86m
- CA$32.82m
Brief: Covalon Announces First Quarter Fiscal 2022 Results
Brief: Covalon Announces Appointment Of Interim CFO
Brief: Covalon Announces CFO Transition
Brief: Covalon Technologies Reports Q4 Earnings Per Share C$0.86
Brief: Covalon Announces Strong Year End And Fourth Quarter Results For Fiscal 2021
Brief: Covalon Reports Q3 Earnings Per Share Of C$0.04
Brief: Covalon Announces Fiscal 2021 Q2 Results
Brief: Covalon Reports Q1 Loss Per Share C$0.01
Brief: Covalon Announces Fiscal 2020 Year-End Results
Brief: Covalon Initiates Strategic Review
Brief: Covalon Announces Q3 Earnings Per Share C$0.01
Brief: Covalon Technologies Reports Q2 Loss Per Share C$0.15
Brief: Covalon Expects to File Interim Financial Statements By Extension Date of July 14
Brief: Covalon Granted Key Antimicrobial Patents In The United States, Canada, And Europe
Brief: Covalon Granted Key Antimicrobial Patents In U.S., Canada and Europe
Brief: Covalon Delays Filing Of Interim Financial Statements Due To Delays Related To Covid-19
Brief: Amir Boloor Joins Covalon's Board Of Directors
Brief: Covalon Says Martin Goldfarb Joins Board
Brief: Covalon Postpones Annual Meeting Of Shareholders Due To Covid-19